AI Signal & Stock Analysis · Avoid ↓
As of Aug 14 2026, 1:04 PM, AkshayaAI's signal for NVS is Avoid ↓; the stock is at $151.24 (-0.32% today); neutral (RSI 43); technical trend is down-trend; news sentiment is positive.
Data as of Aug 14 2026, 1:04 PM. Informational analytics only — not investment advice.
| AI signal (Strength) | Avoid ↓ |
|---|---|
| Price | $151.24 |
| Change today | -0.32% |
| RSI (14) | 42.61 |
| Relative volume | 0.79 |
| Composite (RMTPGV) score | 🔒 members |
| Market cap | $276.9B |
| Forward P/E | 15.45 |
| 52-week high | -11.3% away |
| 52-week low | +25.1% above |
| Technical trend | Down-trend (since 2024-01-26) |
| News sentiment | Positive |
| Sector | Healthcare-Pharma |
| Next earnings | 7/21/2026 8:30:00 AM |
As of Aug 14 2026, 1:04 PM, AkshayaAI assigns NVS (Novartis AG ADR) a Avoid signal. The composite (RMTPGV) score and full factor breakdown are available to signed-in members.
NVS's RSI is neutral (RSI 43). A reading above 70 is typically considered overbought and below 30 oversold.
NVS is trading about 11% below its 52-week high and 25% above its 52-week low as of Aug 14 2026, 1:04 PM.
NVS's next earnings date is 7/21/2026 8:30:00 AM.
NVS is classified under Healthcare-Pharma in AkshayaAI's taxonomy.
AkshayaAI provides AI-generated, informational stock analytics for US and India markets. This is not personalized investment advice. Figures are as of Aug 14 2026, 1:04 PM and may not reflect real-time prices. Always do your own research.
Instant, data-backed answers — free to try.